Asset Publisher

Improved Patient Classification in Chronic Lymphocytic Leukemia

Improved Patient Classification in Chronic Lymphocytic Leukemia

CMM Group Leader Professor Richard Rosenquist Brandell, is one of the main coauthors of a large study recently published in Blood. Nearly 30.000 patients with chronic lymphocytic leukemia (CLL) were included in this study, led by principal investigators who participate in the European Research Initiative on CLL (ERIC), one of which is Richard Rosenquist Brandell. The title of the published article is “Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL”.

CLL is a highly heterogeneous cancer form with disease courses ranging from indolent to aggressive. Common to all patients with this type of leukemia is the clonal expansion and increased numbers of B cells in the blood. The results presented in this paper show that 41% of the patients could be classified into different disease subgroups based on the molecular characterization of the B-cell receptor found on the surface of the leukemic cells. This is the largest study of molecular subsets of CLL performed to date and it corroborates previous data while it refines the characterization and classification even more.

The results provide new possibilities to overcome the heterogeneity of CLL through compartmentalized research and a potential for development of more specific treatments.

Link to the article: https://pubmed.ncbi.nlm.nih.gov/32992344/

Link to the press release on Karolinska Institutet website (in Swedish): https://nyheter.ki.se/ny-molekylar-klassificering-av-kronisk-lymfatisk-leukemi

Richard Rosenquist Brandell

 

Small photo on main page: Magnus Bergström, provided by the Wallenberg Foundations

NEWS

New Molecular Insights into Disease Exacerbation in Multiple Sclerosis

New Molecular Insights into Disease Exacerbation in Multiple Sclerosis Importance of the Atg7 gene for the recovery from inflammation in the central nervous system Multiple...

Grant from Forte to Xia Jiang

Grant from Forte to Xia Jiang Xia Jiang, Assistant Professor in Ingrid Kockum’s Group at CMM, is one of the 11 researchers from Karolinska Institutet who received research grants as a part...

Improved Patient Classification in Chronic Lymphocytic Leukemia

Improved Patient Classification in Chronic Lymphocytic Leukemia CMM Group Leader Professor Richard Rosenquist Brandell, is one of the main coauthors of a large study recently published in ...

Finding Molecular Links between Stress and Depression

Finding Molecular Links between Stress and Depression Vasco Sousa, researcher in Per Svenningson’s Group at CMM, is the first author of a study with the title “P11 deficiency increases...

Nanna Svartz Scholarship for Outstanding Research in Rheumatology 2020

Nanna Svartz Scholarship for Outstanding Research in Rheumatology 2020 The Nanna Svartz scholarship for outstanding research in rheumatology 2020 is awarded to Marie Wahren-Herlenius,...

Susanna Brauner Awarded the Swedish Society of Medicine's Translational Research Prize

Susanna Brauner Awarded the Swedish Society of Medicine's Translational Research Prize Susanna Brauner , Assistant professor and CMM researcher (Fredrik Piehl’s Team) has received the...

Ning Xu Landén 2020 Year’s Winner of the LEO Foundation Award

Ning Xu Landén 2020 Year’s Winner of the LEO Foundation Award Associate Professor Ning Xu Landén, Group Leader at CMM is the winner of this year’s LEO Foundation Award in Region EMEA...

Nils Landegren receives ERC Starting Grant for studying sex differences in the human immune system

Nils Landegren receives ERC Starting Grant for studying sex differences in the human immune system Photo: Hans Ericksson, SSMF Nils Landegren , Researcher at CMM, has been awarded...

Verification project of SARS-CoV-2 antibody tests receives funding from Swelife

Verification project of SARS-CoV-2 antibody tests receives funding from Swelife Photo: Mattias Bronge, Karolinska Institutet A validation project of new SARS-CoV-2 antibody tests,...

Grant to Qiaolin Deng for the single-cell technology core at CMM

Grant to Qiaolin Deng for the single-cell technology core at CMM Qiaolin Deng, private photo We congratulate Associate Professor and CMM Team Leader Qiaolin Deng who received a SFO...